GSK-3β governs inflammation-induced NFATc2 signaling hubs to promote pancreatic cancer progression

We aimed to investigate the mechanistic, functional and therapeutic role of GSK-3β in the regulation and activation of the pro-inflammatory oncogenic transcription factor NFATc2 in pancreatic cancer. Immunohistochemistry, quantitative real-time polymerase chain reaction, immunoblotting, immunofluore...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Mol Cancer Ther
Autors principals: Baumgart, Sandra, Chen, Nai-ming, Zhang, Jin-San, Billadeau, Daniel D., Gaisina, Irina, Kozikowski, Alan P., Singh, Shiv, Fink, Daniel, Ströbel, Philipp, Klindt, Caroline, Zhang, Lizhi, Bamlet, William R., Koenig, Alexander, Hessmann, Elisabeth, Gress, Thomas, Ellenrieder, Volker, Neesse, Albrecht
Format: Artigo
Idioma:Inglês
Publicat: 2016
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6071313/
https://ncbi.nlm.nih.gov/pubmed/26823495
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1535-7163.MCT-15-0309
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars